Tumor of uterus
MONDO:0021353A neoplasm (disease) that involves the uterus.
Also known as: neoplasm of the uterus, neoplasm of uterus, tumor of the uterus, tumor of uterus, tumour of the uterus, uterine neoplasm, uterine neoplasms, uterine tumor
2772 clinical trials for this condition and its sub-types, 11 tagged with Tumor of uterus itself.
Follow this condition to get notified about new trialsWhere it sits in the disease tree
Browse by category →Sub-types of Tumor of uterus
-
Uterine cancer 96 trials · 1,264 incl. sub-types
7 sub-types
- Cervical cancer 576 trials · 700 incl. sub-types Sub-types →
- Endometrial cancer 458 trials · 650 incl. sub-types Sub-types →
- Uterine carcinoma 3 trials · 614 incl. sub-types Sub-types →
- Uterine corpus cancer 33 trials · 85 incl. sub-types Sub-types →
- Uterine carcinosarcoma 23 trials · 32 incl. sub-types Sub-types →
- Placenta cancer 0 trials · 1 incl. sub-types Sub-types →
- Uterine adnexa cancer 0 trials Sub-types →
-
Uterine cervix neoplasm 39 trials · 731 incl. sub-types
5 sub-types
- Cervical cancer 576 trials · 700 incl. sub-types Sub-types →
- Cervical squamous intraepithelial neoplasia 28 trials
- Cervical benign neoplasm 0 trials Sub-types →
- Nabothian cyst 0 trials
- Uterine ligament neoplasm 0 trials Sub-types →
-
Endometrium neoplasm 480 trials · 690 incl. sub-types
4 sub-types
- Endometrial cancer 458 trials · 650 incl. sub-types Sub-types →
- Endometrial stromal tumor 2 trials · 3 incl. sub-types Sub-types →
- Fallopian tube endometrioid tumor 3 trials
- Benign neoplasm of endometrium 0 trials
-
Corpus uteri neoplasm 1 trial · 191 incl. sub-types
6 sub-types
- Benign neoplasm of corpus uteri 0 trials · 109 incl. sub-types Sub-types →
- Uterine corpus cancer 33 trials · 85 incl. sub-types Sub-types →
- Uterine corpus mixed epithelial and mesenchymal neoplasm 0 trials · 14 incl. sub-types Sub-types →
- Mixed endometrial stromal and smooth muscle tumor 0 trials · 9 incl. sub-types Sub-types →
- Primitive neuroectodermal tumor of the corpus uteri 0 trials
- Uterine corpus neuroendocrine neoplasm 0 trials Sub-types →
-
Uterine benign neoplasm 3 trials · 112 incl. sub-types
5 sub-types
- Benign neoplasm of corpus uteri 0 trials · 109 incl. sub-types Sub-types →
- Benign neoplasm of endometrium 0 trials
- Benign neoplasm of placenta 0 trials Sub-types →
- Cervical benign neoplasm 0 trials Sub-types →
- Uterus intravascular leiomyomatosis 0 trials
-
Placenta neoplasm 0 trials · 6 incl. sub-types
3 sub-types
- Hydatidiform mole 3 trials · 5 incl. sub-types Sub-types →
- Placenta cancer 0 trials · 1 incl. sub-types Sub-types →
- Benign neoplasm of placenta 0 trials Sub-types →
Most studied deeper sub-types
-
New drug combo shows promise for Hard-to-Treat HER2 cancers
Disease control OngoingThis study tests a two-drug combination (tucatinib and trastuzumab) in people with advanced solid tumors that have HER2 alterations. The goal is to see if the treatment can shrink or control tumors. About 217 participants with various cancers (like lung, uterine, or bile duct) wi…
Phase 2 • Sponsor: Seagen, a wholly owned subsidiary of Pfizer • Aim: Disease control
Last updated Aug 23, 2026 00:00 UTC
-
New drug targets rare cancer mutation in early trial
Disease control OngoingThis early-phase study tests a new oral drug, ATV-1601, in people with advanced solid tumors or certain breast cancers that have a specific AKT1 E17K mutation. The main goals are to check safety, find the right dose, and see how the drug moves through the body. About 134 adults w…
Phase 1 • Sponsor: Atavistik Bio, Inc • Aim: Disease control
Last updated Aug 09, 2026 00:00 UTC
-
Blood test may help cancer patients avoid nerve damage from chemo
Knowledge-focused PausedThis pilot study aims to see if doctors can consistently measure paclitaxel levels in the blood of cancer patients receiving the drug. The goal is to eventually adjust doses to give enough chemo to fight cancer while reducing the common side effect of nerve damage. The study invo…
Sponsor: Wake Forest University Health Sciences • Aim: Knowledge-focused
Last updated Aug 15, 2026 00:00 UTC